breast cancer
Conditions
Interventions
The intervention consists of a newly developed exercise support app and 6-week online home exercise support (exercise counselling and instruction, once per week, 6 sessions in total, 30 min/session).
(2) an exercise diary (daily symptoms, subjective exercise intensity and feedback on exercise)
(3) monitoring of maximum heart rate during exercise (automatically recorded by a wearable device [Fitbit Inspire2
Fitbit Inc., San Francisco, CA])
(4) motivation to exercise (feedforward based on subjective exercise intensity during exercise [rate of perceived exertion: RPE], feedback comments, provision of incentives and feedback from others wh
(5) checking the status of exercise (dates of exercise, subjective exercise intensity, maximum heart rate and feedback on exercise)
and (6) information on cancer research and exercise. Participants will perform the following exercise program 3 times per week for 12 weeks (36 sessions in total during the study period): a 10-min ses
Sponsors
Suto Akihiko
The Japan Agency for Medical Research and Development
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: (1) women aged over 20 years (2) diagnosis of Stage I-III invasive breast cancer (3) within 13 months of completing initial cancer treatment with curative intent (including hormone therapy and radiation therapy) (4) scoring 1 on a 1-item fatigue numerical rating scale (5) no exercise habits (2 days per week of light sweat-inducing exercise for 30 min/session in a typical week) (6) access to a smart phone (7) willing to provide written informed consent for study participation (8) able to read, write and understand Japanese.
Exclusion criteria
Exclusion criteria: (1) primary physician determined severe cognitive decline (2) primary physician determined exercise risk (3) difficulty performing basic activities (e.g., walking, running, jumping and riding a bicycle) (4) comorbidities affecting physical activity (e.g., anaemia, heart failure, chronic obstructive pulmonary disease and musculoskeletal disease) (5) BMI over 30.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Multidimensional Fatigue Inventory (MFI) | — |
Secondary
| Measure | Time frame |
|---|---|
| Body mass VO2 peak Grip Strength sit to stand test fitbit CRF CFS FACT B HADS PRO CTCAE WHO HPQ EQ 5D 5L medical fee steps sleep time Adverse event adherence LVEF GLS Troponin BNP NT proBNP Framingham Risk Score | — |
Contacts
Public ContactEisuke Ochi
Hosei Univeristy
Outcome results
None listed